Cerebrovascular disease, or stroke is the third leading cause of death in the United States and a major cause of disability. At the present time there is no treatment of proven efficacy in treating or ameliorating strokes. Recent evidence has accumulated suggesting that specific antagonism of postsynaptic glutamate receptors, especially the N-methyl-D-aspartate (NMDA) receptor protects neurons from hypoxic or ischemic injury. Over the last three years my laboratory has shown that dextromethorphan (DM), an NMDA antagonist, and its major metabolite, dextrorphan (DX), have a significant protective effect against focal cerebral ischemia in our rabbit model when given prior to the onset of ischemia and also when administered in a delayed fashion one hour after the onset of ischemia. The purpose of this research is to further elucidate the precise conditions of focal cerebral ischemia that will respond to treatment with DM or DX and to delineate the mechanism of protection. Focal cerebral ischemia will be produced in anesthetized rabbits by transorbital, clip occlusion of the internal carotid artery, anterior cerebral artery and middle cerebral artery. The degree of cerebral ischemia will be determined using electrophysiological (somatosensory evoked potentials), radiological (magnetic resonance imaging), histological and behavioral criteria. Experiments will characterize the dose response curve for both drugs regarding cerebral protection and toxicity, will determine the relative roles of loading versus maintenance drug therapy, and will define the maximal delay after ischemia that these drugs can be administered and still demonstrate neuroprotection. Regional cerebral blood flow will be measured using two techniques (laser Doppler flowmetry and radioactive microspheres to determine whether the drugs' neuroprotective effects and regional selectivity are due to changes in blood flow. The efficacy of these agents will also be examined over a longer period of time (24 hours) and brain levels will be correlated with plasma levels. DM and DX have already been clinically tested and are known to be relatively free of side effects. If the studies outlined in this proposal confirm the benefit of DM or DX in protecting against cerebral ischemia, the implications for treatment of humans with stroke could be profound in terms of reducing neurologic morbidity or mortality. The results from the proposed project will expedite the planning and execution of a clinical study.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS027292-01A2
Application #
3413525
Study Section
Neurology A Study Section (NEUA)
Project Start
1991-01-01
Project End
1994-12-31
Budget Start
1991-01-01
Budget End
1991-12-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Gu, Li-Juan; Xiong, Xiao-Xing; Ito, Takashi et al. (2014) Moderate hypothermia inhibits brain inflammation and attenuates stroke-induced immunodepression in rats. CNS Neurosci Ther 20:67-75
Gu, Lijuan; Xiong, Xiaoxing; Wei, Dingtai et al. (2013) T cells contribute to stroke-induced lymphopenia in rats. PLoS One 8:e59602
Daadi, Marcel M; Hu, Shijun; Klausner, Jill et al. (2013) Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant 22:881-92
Gu, Lijuan; Xiong, Xiaoxing; Zhang, Hongfei et al. (2012) Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke 43:1941-6
Takahashi, T; Steinberg, G K; Zhao, H (2012) Phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 may not always represent its kinase activity in a rat model of focal cerebral ischemia with or without ischemic preconditioning. Neuroscience 209:155-60
Takahashi, Tetsuya; Steinberg, Gary K; Zhao, Heng (2012) Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis 3:226-33
Horie, Nobutaka; Pereira, Marta P; Niizuma, Kuniyasu et al. (2011) Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29:274-85
Andres, Robert H; Horie, Nobutaka; Slikker, William et al. (2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134:1777-89
Andres, Robert H; Choi, Raymond; Pendharkar, Arjun V et al. (2011) The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42:2923-31
Zhao, Heng; Steinberg, Gary (2011) Limited Therapeutic Time Windows of Mild-to-Moderate Hypothermia in a Focal Ischemia Model in Rat. Stroke Res Treat 2011:131834

Showing the most recent 10 out of 85 publications